Brain-derived neurotrophic factor levels in schizophrenia: a systematic review with meta-analysis

Cited by (453)

Items 201–300 of 453

1. BDNF and JNK Signaling Modulate Cortical Interneuron and Perineuronal Net Development: Implications for Schizophrenia-Linked 16p11.2 Duplication Syndrome
   Ashleigh Willis, Judith A. Pratt, BRIAN J. MORRIS · 2020 · Schizophrenia Bulletin
2. Modulating neural plasticity with non-invasive brain stimulation in schizophrenia
   Alkomiet Hasan, Thomas Wobrock, Tarek K. Rajji, Berend Malchow, Zafiris Jeff Daskalakis · 2013 · European Archives of Psychiatry and Clinical Neuroscience
3. Hippocampal volume and the brain-derived neurotrophic factor Val66Met polymorphism in first episode psychosis
   Geoffrey N. Smith, Allen E. Thornton, Donna J. Lang, G. William MacEwan, Thomas S. Ehmann, Lili C. Kopala, Karen A. Tee, Gillian Shiau, Aristotle N. Voineskos, James L. Kennedy et al. · 2011 · Schizophrenia Research
4. Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism differentially predicts hippocampal function in medication-free patients with schizophrenia
   Daniel Paul Eisenberg, Angela M. Ianni, S-M Wei, Philip D. Kohn, Bhaskar S. Kolachana, Jose A. Apud, Daniel R. Weinberger, Karen Faith Berman · 2013 · Molecular Psychiatry
5. Serum proBDNF/BDNF and response to fluvoxamine in drug-naïve first-episode major depressive disorder patients
   Reiji Yoshimura, Taro Kishi, Hikaru Hori, Kiyokazu Atake, Asuka Katsuki, Wakako Nakano-Umene, Atsuko Ikenouchi, Nakao Iwata, Jun Nakamura · 2014 · Annals of General Psychiatry
6. Serum levels of brain-derived neurotrophic factor (BDNF), proBDNF and plasma 3-methoxy-4-hydroxyphenylglycol levels in chronic schizophrenia
   Reiji Yoshimura, Hikaru Hori, Asuka Katsuki, Kiyokazu Atake, Jun Nakamura · 2016 · Annals of General Psychiatry
7. Carbonyl Stress and Microinflammation-Related Molecules as Potential Biomarkers in Schizophrenia
   Tohru Ohnuma, Shohei Nishimon, Mayu Takeda, Takahiro Sannohe, Narimasa Katsuta, Heii Arai · 2018 · Frontiers in Psychiatry
8. Peripheral BDNF: a candidate biomarker of healthy neural activity during learning is disrupted in schizophrenia
   Ashley J. Skilleter, Cynthia Shannon Weickert, Ans Vercammen, Rhoshel Lenroot, Thomas Wesley Weickert · 2014 · Psychological Medicine
9. Peripheral levels of BDNF and opiate-use disorder: literature review and update
   Raúl Felipe Palma-Álvarez, Elena Ros‐Cucurull, Kristopher Amaro-Hosey, Laia Rodríguez-Cintas, Lara Grau‐López, Margarida Corominas, Cristina Sánchez‐Mora, Carlos Roncero · 2017 · Reviews in the Neurosciences
10. Intracellular compartment-specific proteasome dysfunction in postmortem cortex in schizophrenia subjects
    Madeline R. Scott, James H. Meador‐Woodruff · 2019 · Molecular Psychiatry
11. Reduced density of hypothalamic VGF-immunoreactive neurons in schizophrenia: a potential link to impaired growth factor signaling and energy homeostasis
    Stefan Busse, Hans‐Gert Bernstein, Mandy Busse, Hendrik Bielau, Ralf Brisch, Christian Mawrin, Susan Müller, Zóltan Sarnyai, Tomasz Gos, Bernhard Bogerts et al. · 2011 · European Archives of Psychiatry and Clinical Neuroscience
12. Dominant negative DISC1 mutant mice display specific social behaviour deficits and aberration in BDNF and cannabinoid receptor expression
    Ayelet Kaminitz, Ran Barzilay, Hadar Segal‐Gavish, Michal Taler, Daniel Offen, Irit Gil‐Ad, Raphael Mechoulam, Abraham Weizman · 2013 · The World Journal of Biological Psychiatry
13. Val66Met functional polymorphism and serum protein level of brain-derived neurotrophic factor (BDNF) in acute episode of schizophrenia and depression
    Maria Skibińska, Agata Groszewska, Paweł Kapelski, Aleksandra Rajewska‐Rager, Joanna Pawlak, Monika Dmitrzak‐Węglarz, Aleksandra Szczepankiewicz, Joanna Hauser · 2017 · Pharmacological Reports
14. Genetic blockade of adenosine A2A receptors induces cognitive impairments and anatomical changes related to psychotic symptoms in mice
    Maria Moscoso‐Castro, Irene Gracia‐Rubio, Francisco Ciruela, Olga Valverde · 2016 · European Neuropsychopharmacology
15. Examining the effects of the histone methyltransferase inhibitor BIX-01294 on histone modifications and gene expression in both a clinical population and mouse models
    Kayla A. Chase, Benjamin Feiner, Marcia J. Ramaker, Edward Hu, Cherise Rosen, Rajiv P. Sharma · 2019 · PLoS ONE
16. Oroxylin A enhances memory consolidation through the brain-derived neurotrophic factor in mice
    Dong Hyun Kim, Younghwan Lee, Hyung Eun Lee, Se Jin Park, Su Jin Jeon, Se Jin Jeon, Jae Hoon Cheong, Chan Young Shin, Kun Ho Son, Jong Hoon Ryu · 2014 · Brain Research Bulletin
17. Brain-derived neurotrophic factor serum and plasma levels in the treatment of acute schizophrenia with olanzapine or risperidone: 6-week prospective study
    Kudlek Mikulic, Suzan, Mihaljevic-Peles, Alma, Sagud, Marina, Bajs Janovic, Maja, Ganoci, Lana, Grubisin, Jasmina, Kuzman Rojnic, Martina, Vuksan Cusa, Bjanka, Bradaš, Zoran, Božina, Nada · 2017 · Nordic Journal of Psychiatry
18. Systematic Review and Meta-analysis of Exercise Interventions for Psychotic Disorders: The Impact of Exercise Intensity, Mindfulness Components, and Other Moderators on Symptoms, Functioning, and Cardiometabolic Health
    Matthias Rißmayer, Joseph P. Kambeitz, Florian Javelle, Theresa Lichtenstein · 2024 · Schizophrenia Bulletin
19. Early enriched environment prevents cognitive impairment in an animal model of schizophrenia induced by MK-801: Role of hippocampal BDNF
    Mahdiyeh Faatehi, Mohsen Basiri, Akram Nezhadi, Mohammad Shabani, Yaser Masoumi‐Ardakani, Zahra Soltani, Masoumeh Nozari · 2019 · Brain Research
20. BDNF affects the mediating effect of negative symptoms on the relationship between age of onset and cognition in patients with chronic schizophrenia
    Hang Xu, Jiesi Wang, Yongjie Zhou, Dachun Chen, Meihong Xiu, Li Wang, Xiangyang Zhang · 2020 · Psychoneuroendocrinology
21. A Meta-Analysis of Brain-Derived Neurotrophic Factor Effects on Brain Volume in Schizophrenia: Genotype and Serum Levels
    Anthony O. Ahmed, Samantha Kramer, Naama Hofman, John Flynn, Marie C. Hansen, Victoria Martin, Anilkumar Pillai, P.F. Buckley · 2021 · Neuropsychobiology
22. Allosteric Modulation of the Sigma-1 Receptor Elicits Antipsychotic-like Effects
    Jiali Chen, Guangying Li, Pingping Qin, Jiaojiao Chen, Na Ye, John L. Waddington, Xuechu Zhen · 2021 · Schizophrenia Bulletin
23. Ubiquitin–proteasome system, lipid metabolism and DNA damage repair are triggered by antipsychotic medication in human oligodendrocytes: implications in schizophrenia
    Gabriela Seabra, Valéria de Almeida, Guilherme Reis‐de‐Oliveira, Fernanda Crunfli, André Saraiva Leão Marcelo Antunes, Daniel Martins‐de‐Souza · 2020 · Scientific Reports
24. Association of circulating BDNF levels with BDNF rs6265 polymorphism in schizophrenia
    PVSN Kiran Kumar, Prasenjit Mitra, Raghumoy Ghosh, Shailja Sharma, Naresh Nebhinani, Praveen Sharma · 2020 · Behavioural Brain Research
25. Psychogenic Non-Epileptic Seizures; a Narrative Review.
    Ameneh Jafari, Mostafa Rezaei–Tavirani, Mohsen Parvareshi Hamrah, Sanaz Ahmadi Karvigh, Haniyeh Bashi Zadeh Fakhar · 2020 · Archives of Academic Emergency Medicine
26. BDNF in antipsychotic naive first episode psychosis: Effects of risperidone and the immune-inflammatory response system
    Mariane Nunes Noto, Michael H. J. Maes, Sandra Odebrecht Vargas Nunes, Vanessa Ota, Daniel Azevedo Cavalcante, Giovany Oliveira, Ana Carolina Rossaneis, Waldiceu Aparecido Verri Jr, Quirino Cordeiro, Sintia Iole Belangero et al. · 2021 · Journal of Psychiatric Research
27. Corticosterone antagonist or TrkB agonist attenuates schizophrenia-like behavior in a mouse model combining Bdnf-e6 deficiency and developmental stress
    Yanhui Chen, Shangjin Li, Tianyi Zhang, Feng Yang, Bai Lu · 2022 · iScience
28. The Effect of Recombinant Erythropoietin on Plasma Brain Derived Neurotrophic Factor Levels in Patients with Affective Disorders: A Randomised Controlled Study
    Maj Vinberg, Kamilla Woznica Miskowiak, Pernille Højman, Maria Pedersen, Lars Vedel Kessing · 2015 · PLoS ONE
29. Maternal deprivation disrupts mitochondrial energy homeostasis in the brain of rats subjected to ketamine-induced schizophrenia
    Alexandra Ioppi Zugno, Felipe Damázio Pacheco, Josiane Budni, Mariana Bittencourt de Oliveira, Lara Canever, Alexandra S. Heylmann, Patrícia Gomes Wessler, Flávia da Rosa Silveira, Gustavo Antunes Mastella, Cinara Ludwig Gonçalves et al. · 2015 · Metabolic Brain Disease
30. Important unanswered questions about adult neurogenesis in schizophrenia
    Christin Weissleder, Hayley F. North, Cynthia Shannon Weickert · 2019 · Current Opinion in Psychiatry
31. Brain Derived Neurotrophic Factor and Cognitive Dysfunction in the Schizophrenia-Bipolar Spectrum: A Systematic Review and Meta-Analysis
    Z.B. Dombi, István Szendi, Philip W. J. Burnet · 2022 · Frontiers in Psychiatry
32. Altered BDNF is correlated to cognition impairment in schizophrenia patients with tardive dyskinesia
    Jing Qin Wu, Da Chun Chen, Yun Tan, Shuping Tan, Li Hui, Menghan Lv, Jair C. Soares, Xiang Yang Zhang · 2014 · Psychopharmacology
33. Stably BDNF-GFP expressing embryonic stem cells exhibit a BDNF release-dependent enhancement of neuronal differentiation
    Julia Leschik, Robert Eckenstaler, Katja Nieweg, Petra Lichtenecker, Tanja Brigadski, Kurt Gottmann, Volkmar Leßmann, Beat Lutz · 2013 · Journal of Cell Science
34. Converging Evidence Points to BDNF as Biomarker of Depressive Symptoms in Schizophrenia-Spectrum Disorders
    Mirko Manchia, Ulker Isayeva, Roberto Collu, Diego Primavera, Luca Deriu, Edoardo Caboni, Maria Novella Iaselli, Davide Sundas, Massimo Tusconi, Federica Pinna et al. · 2022 · Brain Sciences
35. Peripheral brain-derived neurotrophic factor (BDNF) and salivary cortisol levels in college students with different levels of academic stress. Study protocol
    Juan-Luis Castillo-Navarrete, Alejandra Guzmán-Castillo, Claudio Bustos, Romina Rojas · 2023 · PLoS ONE
36. Investigating the Impacts of Diet, Supplementation, Microbiota, Gut–Brain Axis on Schizophrenia: A Narrative Review
    Izabela Zajkowska, Patrycja Niczyporuk, Agata Dominika Urbaniak, Natalia Tomaszek, Stefan Modzelewski, Napoleon Waszkiewicz · 2024 · Nutrients
37. Serum brain-derived neurotrophic factor and cortical thickness are differently related in patients with schizophrenia and controls
    André Zugman, Mariana Pedrini, Ary Gadelha, Matthew J. Kempton, Cristiano de Souza Noto, Rodrigo Barbachan Mansur, Marcos Leite Santoro, Clarissa Severino Gama, Rodrigo A. Bressan, Philip K. McGuire et al. · 2015 · Psychiatry Research Neuroimaging
38. The relationship between serum brain-derived neurotrophic factor (BDNF) and cardiometabolic indices in schizophrenia
    Milawaty Nurjono, Yi Hang Tay, Jimmy Lee · 2014 · Schizophrenia Research
39. Serum brain-derived neurotrophic factors in Taiwanese patients with drug-naïve first-episode schizophrenia: Effects of antipsychotics
    Yu‐Jie Chiou, Tiao‐Lai Huang · 2016 · The World Journal of Biological Psychiatry
40. Association of serum brain derived neurotropic factor with duration of drug-naive period and positive-negative symptom scores in drug naive schizophrenia
    Abdurrahim Bakirhan, Şafak Yalçın Şahiner, İsmail Volkan Şahiner, Yasir Şafak, Erol Göka · 2017 · PLoS ONE
41. Effects of early trauma on psychosis development in clinical high-risk individuals and stability of trauma assessment across studies: a review.
    Samantha L. Redman, Cheryl Mary Corcoran, David Kimhy, Dolores Malaspina · 2017 · PubMed
42. Serum BDNF Is Positively Associated With Negative Symptoms in Older Adults With Schizophrenia
    Sasha S. Binford, Erin M. Hubbard, Elena Flowers, Bruce L. Miller, Heather C. Leutwyler · 2017 · Biological Research For Nursing
43. Dysregulation of auditory neuroplasticity in schizophrenia
    Patrice Voss, Maryse E. Thomas, Gerson D. Guercio, Etienne de Villers‐Sidani · 2018 · Schizophrenia Research
44. Association study of BDNF and DRD3 genes with alcohol use disorder in Schizophrenia
    Clement C.H. Zai, Mirko Manchia, Gwyneth C. Zai, Julia Woo, Arun Kumar Tiwari, Vincenzo De Luca, James L. Kennedy · 2018 · Neuroscience Letters
45. Cytokine-, Neurotrophin-, and Motor Rehabilitation-Induced Plasticity in Parkinson’s Disease
    Gabriella Policastro, Matteo Brunelli, Michèle Tinazzi, Cristiano Chiamulera, Dwaine F. Emerich, Giovanna Paolone · 2020 · Neural Plasticity
46. Fingolimod ameliorates schizophrenia‐like cognitive impairments induced by phencyclidine in male rats
    Xueli Yu, Xueyu Qi, Wei Long, Liansheng Zhao, Wei Deng, Wanjun Guo, Qiang Wang, Xiaohong Ma, Xun Hu, Peiyan Ni et al. · 2022 · British Journal of Pharmacology
47. Brain-derived neurotrophic factor (BDNF) in schizophrenia research: a quantitative review and future directions
    Rozaziana Ahmad, Khairunnuur Fairuz Azman, Rosliza Yahaya, Nazlahshaniza Shafin, Norsuhana Omar, Asma Hayati Ahmad, Rahimah Zakaria, Adi Wijaya, Zahiruddin Othman · 2023 · AIMS neuroscience
48. Stress, Environment and Early Psychosis
    Lida‐Alkisti Xenaki, Stefanos Dimitrakopoulos, Mirjana Selaković, Nikos C. Stefanis · 2023 · Current Neuropharmacology
49. The Impact of Aging, Psychotic Symptoms, Medication, and Brain-Derived Neurotrophic Factor on Cognitive Impairment in Japanese Chronic Schizophrenia Patients
    Kiyokazu Atake, Tomoyuki Nakamura, Nobuhisa Ueda, Hikaru Hori, Asuka Katsuki, Reiji Yoshimura · 2018 · Frontiers in Psychiatry
50. The association between serum insulin-like growth factor 1 and cognitive impairments in patients with schizophrenia
    Xue-lin Chao, Shuzhen Jiang, Jian Xiong, Jin‐Qiong Zhan, Kun Yan, Yuan‐Jian Yang, Li-ping Jiang · 2019 · Psychiatry Research
51. Potential Neurochemical and Neuroendocrine Effects of Social Distancing Amidst the COVID-19 Pandemic
    Limin Wang, Ghulam Nabi, Tonghe Zhang, Yuefeng Wu, Dongming Li · 2020 · Frontiers in Endocrinology
52. Decreased Peripheral BDNF Levels and Cognitive Impairment in Late-Life Schizophrenia
    Lijuan Huo, Zhiwei Zheng, Xiaobing Lu, Fengchun Wu, Yuping Ning, Xiangyang Zhang · 2021 · Frontiers in Psychiatry
53. Deregulatory miRNA-BDNF Network Inferred from Dynamic Expression Changes in Schizophrenia
    Xiaoqian Fu, Yansong Liu, Ancha V. Baranova, Fuquan Zhang · 2022 · Brain Sciences
54. Inflammatory cytokines and growth factors were not associated with psychosis liability or childhood trauma
    Jacqueline Counotte, Veerle Bergink, Roos Pot-Kolder, Hemmo A. Drexhage, Hans Wijbrand Hoek, Wim Veling · 2019 · PLoS ONE
55. Changes of BDNF exon IV DNA methylation are associated with methamphetamine dependence
    Sri-arun Iamjan, Samur Thanoi, Paritat Watiktinkorn, Helene Fachim, Caroline Dalton, Sutisa Nudmamud‐Thanoi, Gavin P. Reynolds · 2021 · Epigenomics
56. Lower Brain-Derived Neurotropic Factor Levels in Untreated Adolescents With First-Episode Psychosis
    Şeref Şimşek, Salih Gençoğlan, Tuğba Yüksel, İbrahim Kaplan, Hüseyin Aktaş · 2015 · Journal of Clinical Psychopharmacology
57. Safety and Efficacy of Adjunctive Θ Burst Repetitive Transcranial Magnetic Stimulation to Right Inferior Parietal Lobule in Schizophrenia Patients With First-Rank Symptoms
    Sai Krishna Tikka, S. Haque Nizamie, G.M. Venkatesh Babu, Nidhi Aggarwal, Archana Kumari Das, Nishant Goyal · 2016 · Journal of Ect
58. Superoxide Dismutase, BDNF, and Cognitive Improvement in Drug-Naive First-Episode Patients With Schizophrenia: A 12-Week Longitudinal Study
    Zhiwei Wu, Qinqin Liu, Yinghua Zhang, Xiaoni Guan, Meihong Xiu, Xiangyang Zhang · 2021 · The International Journal of Neuropsychopharmacology
59. BDNF: New Views of an Old Player in Traumatic Brain Injury
    Lauren P. Giesler, Richelle Mychasiuk, Sandy R. Shultz, Stuart J. McDonald · 2023 · The Neuroscientist
60. Biomarker-Guided Tailored Therapy
    Jessica B. Lydiard, Charles B. Nemeroff · 2019 · Advances in experimental medicine and biology
61. A randomized controlled trial of exercise on augmenting the effects of cognitive remediation in persons with severe mental illness
    Susan R. McGurk, Michael W. Otto, Daniel Fulford, Zachary Cutler, Leonard P. Mulcahy, Sai Snigdha Talluri, Wei Qiao Qiu, Qini Gan, Ivy Tran, Laura Turner et al. · 2021 · Journal of Psychiatric Research
62. Comparison of serum BDNF levels in deficit and nondeficit chronic schizophrenia and healthy controls
    Alicia Valiente-Gómez, Benedikt Lorenz Amann, Frederic Mármol, Cristina Oliveira, Ana Messeguer, Amàlia Lafuente, Edith Pomarol‐Clotet, Miquel Bernardo · 2014 · Psychiatry Research
63. BDNF rescues prefrontal dysfunction elicited by pyramidal neuron-specific DTNBP1 deletion in vivo
    Wen Zhang, Kathryn M. Daly, Bo Liang, Lifeng Zhang, Xuan Li, Yun Li, Da‐Ting Lin · 2016 · Journal of Molecular Cell Biology
64. Trauma Profile in Egyptian Adolescents With First-Episode Schizophrenia: Relation to Psychopathology and Plasma Brain-Derived Neurotrophic Factor
    Fawzi, Mounir H., Kira, Ibrahim A., Fawzi, Mohab M., Mohamed, Hanan E., Fawzi, Maggie M. · 2013 · Journal of Nervous & Mental Disease
65. The role of BDNF and NGF plasma levels in first-episode schizophrenia: A longitudinal study
    Albert Martínez-Pinteño, Gisela Mezquida, Miquel Bioque, Jose M. López-Ilundain, Álvaro Andreu-Bernabeu, Eric P. Zorrilla, Anna Mané, Roberto Rodríguez–Jiménez, Iluminada Corripio, Salvador Sarró et al. · 2022 · European Neuropsychopharmacology
66. Markers of Schizophrenia—A Critical Narrative Update
    Beata Galińska-Skok, Napoleon Waszkiewicz · 2022 · Journal of Clinical Medicine
67. Biomarkers for Psychosis: Are We There Yet? Umbrella Review of 1478 Biomarkers
    Paola Fuentes‐Claramonte, Andrés Estradé, Aleix Solanes, Valentina Ramella‐Cravaro, María Ángeles García‐León, Javier de Diego-Adeliño, Conrad Molins, Eric Fung, Marc Valentí, Gerard Anmella et al. · 2024 · Schizophrenia Bulletin Open
68. Alzheimer's Disease Risk Gene,GAB2, is Associated with Regional Brain Volume Differences in 755 Young Healthy Twins
    Derrek P. Hibar, Neda Jahanshad, Jason L. Stein, Omid Kohannim A, Arthur W. Toga, Sarah Elizabeth Medland, Narelle K. Hansell, Katie Louise McMahon, Greig Ian de Zubicaray, Grant W. Montgomery et al. · 2012 · Twin Research and Human Genetics
69. Suicide Attempt, Clinical Correlates, and BDNF Val66Met Polymorphism in Chronic Patients With Schizophrenia
    H. Xia, Guang-Ya Zhang, Xiangdong Du, Yingyang Zhang, Guang-Zhong Yin, Jing Dai, Man-Xi He, J. Soares, Xiaosi Li, Xiang-Yang Zhang · 2017 · Neuropsychology
70. Increased plasma Brain-Derived Neurotrophic Factor (BDNF) levels in females with schizophrenia
    Cynthia Shannon Weickert, Cynthia H. Lee, Rhoshel Lenroot, Jason M. Bruggemann, Cherrie Ann Galletly, Dennis Liu, Ryan P. Balzan, Anilkumar Pillai, P.F. Buckley, Thomas Wesley Weickert · 2019 · Schizophrenia Research
71. Understanding Schizophrenia as a Disorder of Consciousness: Biological Correlates and Translational Implications from Quantum Theory Perspectives
    Ganesan Venkatasubramanian · 2015 · Clinical Psychopharmacology and Neuroscience
72. Decreased serum levels of brain-derived neurotrophic factor in schizophrenic patients with deficit syndrome
    Yakup Albayrak, Nurkan Aksoy, Murat Kuloğlu, Kenji Hashimoto, Esra Akyol, Murat Beyazyüz · 2015 · Neuropsychiatric Disease and Treatment
73. Plasma brain-derived neurotrophic factor (BDNF) in Egyptian children with attention deficit hyperactivity disorder
    Reem H. El-Ghamry, Mona El-Sheikh, Marwa Abdel Meguid, Safi Nagib, Dina Aly El‐Gabry · 2021 · Middle East Current Psychiatry
74. BDNF Val66Met and spontaneous dyskinesias in non-clinical psychosis
    Vijay Anand Mittal, Andrew Smolen, Derek J. Dean, Andrea Pelletier‐Baldelli, Jessica R. Lunsford‐Avery, Ashley K. Smith · 2012 · Schizophrenia Research
75. Adolescent testosterone influences BDNF and TrkB mRNA and neurotrophin–interneuron marker relationships in mammalian frontal cortex
    Tertia D. Purves-Tyson, Katherine M. Allen, Samantha J. Fung, Debora A. Rothmond, Pam L. Noble, David J. Handelsman, Cynthia Shannon Weickert · 2015 · Schizophrenia Research
76. The Effects of Curcumin on Brain-Derived Neurotrophic Factor Expression in Neurodegenerative Disorders
    Shabnam Radbakhsh, Alexandra E. Butler, Seyed Adel Moallem, Amirhossein Sahebkar · 2023 · Current Medicinal Chemistry
77. Psychedelics and schizophrenia: a double-edged sword
    Jacopo Sapienza, Francesca Martini, Stefano Comai, Roberto Cavallaro, Marco Spangaro, Danilo De Gregorio, Marta Bosia · 2024 · Molecular Psychiatry
78. Does metabolic status affect serum levels of BDNF and MMP-9 in patients with schizophrenia?
    Jaśmina Arabska, Aleksandra Margulska, Dominik Strzelecki, Adam Wysokiński · 2019 · Nordic Journal of Psychiatry
79. Brain-Derived neurotrophic factor (BDNF) plasma level increases in patients with resistant schizophrenia treated with electroconvulsive therapy (ECT)
    Ola Omar Shahin, Sherif M. Gohar, Walaa Ibrahim, Shirin M. El-Makawi, Walaa Fakher, Dina Badie Taher, Mai Abdel Samie, Mohamed Abd El Fatah Khalil, Alia Adel Saleh · 2022 · International Journal of Psychiatry in Clinical Practice
80. Sex Differences in Psychosis: Focus on Animal Models
    Andrea Gogos, Maarten van den Buuse · 2022 · Current topics in behavioral neurosciences
81. Dysregulated Methylation Patterns in Exon IV of the Brain-Derived Neurotrophic Factor (BDNF) Gene in Nicotine Dependence and Changes in BDNF Plasma Levels During Smoking Cessation
    Kerim Abdelkhalek, Mathias Rhein, Maximilian Deest, Vanessa Buchholz, Stefan Bleich, Ralf Lichtinghagen, Benjamin Vyssoki, Helge Frieling, Marc Andre Nicolas Muschler, Phileas Johannes Proskynitopoulos et al. · 2022 · Frontiers in Psychiatry
82. Genetic Variations of PIP4K2A Confer Vulnerability to Poor Antipsychotic Response in Severely Ill Schizophrenia Patients
    Harpreet Kaur, Ajay Jajodia, Sandeep Grover, Ruchi Baghel, Meenal Gupta, Sanjeev Jain, Ritushree Kukreti · 2014 · PLoS ONE
83. Is Serum BDNF Altered in Acute, Short- and Long-Term Recovered Restrictive Type Anorexia Nervosa?
    Jonas L. Steinhäuser, Joseph A. King, Friederike I. Tam, Maria Seidel, Ronald Biemann, Marie‐Louis Wronski, Daniel Geisler, Veit Roessner, Stefan Ehrlich · 2021 · Nutrients
84. Biomarker Identification in Psychiatric Disorders: From Neuroscience to Clinical Practice
    Mahdi Razafsha, Aunali S. Khaku, H. Azari, Ali Alawieh, Hura Behforuzi, Bilal H. Fadlallah, F. Kobeissy, Kevin K. W. Wang, M. Gold · 2015 · Journal of Psychiatric Practice
85. Relationship between Brain-Derived Neurotrophic Factor and Schneiderian First Rank Symptoms in Antipsychotic-Naïve Schizophrenia
    Sunil V. Kalmady, Ganesan Venkatasubramanian, Venkataram Shivakumar, Dania Alphonse Jose, Vasanthapuram Ravi, Bangalore N. Gangadhar · 2013 · Frontiers in Psychiatry
86. The Effects of Treatment in Psychotic Disorders—Changes in BDNF Levels and Clinical Outcomes: Systematic Review
    Anna Mosiołek, Jadwiga Mosiołek · 2023 · International Journal of Environmental Research and Public Health
87. Effects of psychotropic drugs on brain plasticity in humans
    Michael Paulzen, Tanja Veselinović, Gerhard Gründer · 2014 · Restorative Neurology and Neuroscience
88. Serum concentrations of brain-derived neurotrophic factor and mental disorders in imprisoned women
    Renata Maria Dotta Panichi, Helena Dias de Castro Bins, Juliana Tramontina, Keila Maria Mendes Ceresér, Bianca Wollenhaupt de Aguiar, André Vinícius Contri Paz, Jose Taborda · 2015 · Brazilian Journal of Psychiatry
89. The "selfish brain" hypothesis for metabolic abnormalities in bipolar disorder and schizophrenia
    Rodrigo Barbachan Mansur, Elisa Macedo Brietzke · 2012 · Trends in Psychiatry and Psychotherapy
90. Rapid and simple analysis of disease-associated biomarkers of Taiwanese patients with schizophrenia using matrix-assisted laser desorption ionization mass spectrometry
    Tiao‐Lai Huang, Li‐Hua Lo, Jentaie Shiea, Hung Su · 2017 · Clinica Chimica Acta
91. The importance of oxidative biomarkers in diagnosis, treatment, and monitoring schizophrenia patients
    Elżbieta Cecerska‐Heryć, Aleksandra Polikowska, Natalia Maria Serwin, Anna Michalczyk, Patrycja Stodolak, Małgorzata Goszka, Martyn Zoń, Marta Budkowska, Ernest Marek Tyburski, Piotr Podwalski et al. · 2024 · Schizophrenia Research
92. Effects of Antipsychotics on Dentate Gyrus Stem Cell Proliferation and Survival in Animal Models: A Critical Update
    Gerburg Keilhoff, Paolo Fusar‐Poli, Axel Becker · 2012 · Neural Plasticity
93. BDNF serum levels in schizophrenic patients during treatment augmentation with sarcosine (results of the PULSAR study)
    Dominik Strzelecki, Olga Kałużyńska, Adam Wysokiński · 2016 · Psychiatry Research
94. Does genetic BDNF deficiency in rats interact with neurotransmitter control of prepulse inhibition? Implications for schizophrenia
    M. van den Buuse, D. Biel, Kathrin Radscheit · 2017 · Progress in Neuro-psychopharmacology and Biological Psychiatry
95. Levels of Serum Brain-Derived Neurotropic Factor in Individuals at Ultra-High Risk for Psychosis—Findings from the Longitudinal Youth at Risk Study (LYRIKS)
    Jie Yin Yee, Tih-Shih W. Lee, Jimmy Lee · 2018 · The International Journal of Neuropsychopharmacology
96. Spines, Synapses, and Schizophrenia
    Alfredo Ramos‐Miguel, Alasdair M. Barr, William G. Honer · 2015 · Biological Psychiatry
97. Plasma biomarkers in adolescents with schizophrenia‐spectrum disorder
    Przemyslaw Temistokles Zakowicz, Maria Skibińska, Filip Waśniewski, Bartosz Skulimowski, Joanna Pawlak · 2023 · Early Intervention in Psychiatry
98. Plasma levels of neurotrophin 4/5, NGF and pro-BDNF influence transition to mental disorders in a sample of individuals at ultra-high risk for psychosis
    Alexandre Andrade Loch, Marcel Tavares Camilo Pinto, Júlio César Andrade, Leonardo Peroni de Jesus, Matheus Wanderley de Medeiros, Natalia Mansur Haddad, Martinus Theodorus van de Bilt, Leda Leme Talib, Wagner F. Gattaz · 2023 · Psychiatry Research
99. The Influence of Electroconvulsive Therapy (ECT) on Brain-Derived Neurotrophic Factor (BDNF) Plasma Level in Patients with Schizophrenia—A Systematic Review and Meta-Analysis
    Anna Maria Szota, Beata Kowalewska, Małgorzata M. Ćwiklińska-Jurkowska, W. Dróżdż · 2023 · Journal of Clinical Medicine
100. BDNF gene Val66Met polymorphisms as a predictor for clinical presentation in schizophrenia – recent findings
     Adriana Farcas, Charles C.T. Hindmarch, Felicia Iftene · 2023 · Frontiers in Psychiatry